Tokyo Tape
Sign in
← Qol Holdings

Quarterly report · Q1

3034.TEDINET S100OZXA
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥40.5bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥166.2bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥40.4bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥1.7bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥1.8bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥1.8bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥10.1bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.9bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥1.8bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥1.8bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥1.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.0bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥999m2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥1.0bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥98.1bnat 2022-06-30Cons.Assets
Total assets¥96.0bnat 2022-03-31Cons.Assets
Total assets¥101.4bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥53.7bnat 2022-06-30Cons.Liabilities
Total liabilities¥52.1bnat 2022-03-31Cons.Liabilities
Net assets / equity¥44.5bnat 2022-06-30Cons.Net assets
Net assets / equity¥43.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥39.6bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥18.4bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥16.7bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥27.182022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥149.512021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.212021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio45.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio45.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.0%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥77m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥77m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥830m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2022-04-01 → 2022-06-30¥37.2bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2022-04-01 → 2022-06-30¥37.2bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥17m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.1bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-06-30¥3.5bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-06-30¥3.4bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥60m
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-06-30¥349m
—segment totalrevenue2022-04-01 → 2022-06-30¥40.6bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥40.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥77m
—segment totalsegment profit2022-04-01 → 2022-06-30¥2.5bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥80m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥80m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥770m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2021-04-01 → 2021-06-30¥37.2bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2021-04-01 → 2021-06-30¥37.2bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥15m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2021-04-01 → 2021-06-30¥2.3bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue2021-04-01 → 2021-06-30¥3.2bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue external2021-04-01 → 2021-06-30¥3.2bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥64m
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentsegment profit2021-04-01 → 2021-06-30¥311m
—segment totalrevenue2021-04-01 → 2021-06-30¥40.4bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥40.4bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥80m
—segment totalsegment profit2021-04-01 → 2021-06-30¥2.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 350
ItemContextValueUnit
Valuation difference on available for sale securitiesPrior1YearInstant-14000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-12000000JPY
Valuation and translation adjustmentsPrior1YearInstant-14000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-12000000JPY
Non controlling interestsPrior1YearInstant45000000JPY
Non controlling interestsCurrentQuarterInstant43000000JPY
Net assetsPrior1YearInstant43881000000JPY
Net assetsCurrentQuarterInstant44450000000JPY
Liabilities and net assetsPrior1YearInstant95984000000JPY
Liabilities and net assetsCurrentQuarterInstant98114000000JPY
Net salesPrior1YTDDuration40350000000JPY
Net salesCurrentYTDDuration40550000000JPY
Cost of salesPrior1YTDDuration35305000000JPY
Cost of salesCurrentYTDDuration35455000000JPY
Gross profitPrior1YTDDuration5044000000JPY
Gross profitCurrentYTDDuration5095000000JPY
Selling general and administrative expensesPrior1YTDDuration3217000000JPY
Selling general and administrative expensesCurrentYTDDuration3436000000JPY
Operating incomePrior1YTDDuration1827000000JPY
Operating incomeCurrentYTDDuration1658000000JPY
House rent income noiPrior1YTDDuration8000000JPY
House rent income noiCurrentYTDDuration10000000JPY
Commission fee noiPrior1YTDDuration14000000JPY
Commission fee noiCurrentYTDDuration28000000JPY
Subsidy income noiPrior1YTDDuration3000000JPY
Subsidy income noiCurrentYTDDuration0JPY
Guarantee commission received noiPrior1YTDDuration14000000JPY
Guarantee commission received noiCurrentYTDDuration14000000JPY
Other noiPrior1YTDDuration65000000JPY
Other noiCurrentYTDDuration87000000JPY
Non operating incomePrior1YTDDuration106000000JPY
Non operating incomeCurrentYTDDuration141000000JPY
Interest expenses noePrior1YTDDuration26000000JPY
Interest expenses noeCurrentYTDDuration20000000JPY
Other noePrior1YTDDuration11000000JPY
Other noeCurrentYTDDuration19000000JPY
Non operating expensesPrior1YTDDuration38000000JPY
Non operating expensesCurrentYTDDuration39000000JPY
Ordinary incomePrior1YTDDuration1895000000JPY
Ordinary incomeCurrentYTDDuration1760000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration0JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration0JPY
Extraordinary incomePrior1YTDDuration0JPY
Extraordinary incomeCurrentYTDDuration0JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration9000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration5000000JPY
Loss on valuation of subsidiaries stocks elPrior1YTDDuration49000000JPY
Loss on valuation of subsidiaries stocks elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration58000000JPY
Extraordinary lossCurrentYTDDuration5000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass